University of Oxford: Malaria trials

The registry lists 114 Malaria studies with University of Oxford as lead sponsor. 4 are open to participants now and 10 have results posted.

Early Phase 1 3Phase 1 47Phase 2 33Phase 3 13Phase 4 5No phase 38(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of AdCh63 AMA1 Alone and With MVA AMA1CompletedNCT01095055Phase 1
• Incidence of Vivax Along the Thai Burma BorderCompletedNCT01076868Not applicable
• Study on the Treatment of Vivax MalariaCompletedNCT01074905Phase 3
• Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in PregnancyCompletedNCT01054248Phase 3
• A Study of the Safety and Effectiveness of Two New Malaria VaccinesCompletedNCT01003314Phase 1/2
• A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum MalariaCompletedNCT00984763Phase 1/2
• Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western CambodiaWithdrawnNCT00936767Phase 2/3
• A Study to Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria ParasitesCompletedNCT00890760Phase 1/2
• A Study of AdCh63 ME-TRAP Alone and With MVA ME-TRAPCompletedNCT00890019Phase 1
• Ultrasound Study in Pregnant Women With MalariaCompletedNCT00840502
• Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum MalariaCompletedNCT00692627
• A Comparative Study of Artekin With Standard Malarial Treatment Regimes in AfghanistanCompletedNCT00682578Phase 3
• Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western CambodiaCompletedNCT00493363Not applicable
• Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost RegimenCompletedNCT00408668Phase 1/2